SARS‐CoV‐2 R.1 lineage variants that prevailed in Tokyo in March 2021-Reference-Cited by-同舟云学术

SARS‐CoV‐2 R.1 lineage variants that prevailed in Tokyo in March 2021

Published:2021-08-05 Issue:12 Volume:93 Page:6833-6836
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Nagano Katsutoshi¹,Tani‐Sassa Chihiro¹,Iwasaki Yumi¹,Takatsuki Yuna¹,Yuasa Sonoka¹,Takahashi Yuta¹,Nakajima Jun¹,Sonobe Kazunari¹,Ichimura Naoya¹,Nukui Yoko²,Takeuchi Hiroaki³^ORCID,Tanimoto Kousuke⁴⁵,Tanaka Yukie⁵,Kimura Akinori⁶,Tohda Shuji¹^ORCID

Affiliation:

1. Clinical Laboratory Tokyo Medical and Dental University (TMDU) Hospital Tokyo Japan

2. Infection Control and Prevention Tokyo Medical and Dental University (TMDU) Hospital Tokyo Japan

3. Department of Molecular Virology Tokyo Medical and Dental University (TMDU) Tokyo Japan

4. Genome Laboratory, Medical Research Institute Tokyo Medical and Dental University (TMDU) Tokyo Japan

5. Research Core, Institute of Research Tokyo Medical and Dental University (TMDU) Tokyo Japan

6. Institute of Research Tokyo Medical and Dental University (TMDU) Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27240

Reference8 articles.

1. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

2. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

3. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

4. Detection of SARS‐CoV‐2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil;Martins AF;Euro Surveill,2021

5. PANGO lineages database. Accessed May 20 2021.https://cov-lineages.org/lineages/lineage_R.1.html

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1;Viruses;2022-11-09

3. Viral load of SARS‐CoV‐2 Omicron is not high despite its high infectivity;Journal of Medical Virology;2022-07-11

4. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19;Frontiers in Immunology;2022-04-05

5. Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens;2022-01-11